Chen, Ji
Sun, Meng
Adeyemo, Adebowale
Pirie, Fraser
Carstensen, Tommy
Pomilla, Cristina
Doumatey, Ayo P.
Chen, Guanjie
Young, Elizabeth H.
Sandhu, Manjinder
Morris, Andrew P.
Barroso, InĂªs
McCarthy, Mark I.
Mahajan, Anubha
Wheeler, Eleanor
Rotimi, Charles N.
Motala, Ayesha A.
Funding for this research was provided by:
The South African Sugar Association
Servier South Africa
Wellcome (WT206194)
Victor Daitz Foundation
CRGGH (1ZIAHG200362)
MRC (G0601261)
NIH (U01DK105535)
Article History
Received: 12 September 2018
Accepted: 22 March 2019
First Online: 2 May 2019
Duality of interest
: TC owns shares in Novo Nordisk, Roche and Teva Pharmaceutical Industries. IB and spouse own stock in GlaxoSmithKline and Incyte Corporation. MIM serves on advisory panels for Pfizer, Novo Nordisk and Zoe Global; has received honoraria from Pfizer, Novo Nordisk and Lilly; has stock options in Zoe Global; and has received research funding from AbbVie, AstraZeneca, Boehringer Ingelheim, Lilly, Janssen, Merck, Novo Nordisk, Pfizer, Roche, Sanofi Aventis, Servier and Takeda. The views expressed in this article are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.